ANIP
Ani Pharmaceuticals Inc
$65.62
Earnings Summary
Revenue | $131.65Mn |
Net Profits | $1.16Mn |
Net Profit Margins | 0.88% |
Highlights
Ani Pharmaceuticals Inc’s revenue jumped 39.71% since last year same period to $131.65Mn in the Q4 2023. On a quarterly growth basis, Ani Pharmaceuticals Inc has generated -0.13% fall in its revenue since last 3-months.
Ani Pharmaceuticals Inc’s net profit jumped 127.22% since last year same period to $1.16Mn in the Q4 2023. On a quarterly growth basis, Ani Pharmaceuticals Inc has generated -88.38% fall in its net profits since last 3-months.
Ani Pharmaceuticals Inc’s net profit margin jumped 119.48% since last year same period to 0.88% in the Q4 2023. On a quarterly growth basis, Ani Pharmaceuticals Inc has generated -88.36% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ani Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.98 |
EPS Estimate Current Year | 0.98 |
Highlights
Ani Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.98 - a 13.95% jump from last quarter’s estimates.
Ani Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.98.
Key Ratios
Key ratios of the Ani Pharmaceuticals Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 1 |
Highlights
Ani Pharmaceuticals Inc’s earning per share (EPS) jumped 31.58% since last year same period to 1 in the Q4 2023. This indicates that the Ani Pharmaceuticals Inc has generated 31.58% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-08 | 0.35 | 1.17 | 234.29% |
2024-02-29 | 0.86 | 1 | 16.28% |
2023-11-08 | 0.84 | 1.27 | 51.19% |
2023-08-09 | 0.68 | 1.28 | 88.24% |
₹0 US Stocks a/c Opening Fee